Viruses such as SARS-CoV-2, influenza virus and others travel from person to person essentially by hitchhiking on aerosols. These are finely dispersed particles containing liquid suspended in the air that an infected person expels when coughing, sneezing, or simply exhaling, and can be inhal
Haryana / Delhi-NCR / Chandigarh / Ludhiana/ Punjab / Ghaziabad, December 15 (ANI/PNN): Swan in Murthal, Garam Dharam Dhaba which is one of the well-known destinations for all the North Indian cuisine with authentic flavours has announced the perfect wholesome menu for this winter.
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections. The study shows how a portion of the SARS-CoV-2 "spike" protein can damage cell barriers that line the inside of blood vessels within orga
This comes as WHO estimates that at least 90 per cent of the world's population now has some level of immunity to SARS-CoV-2, due to prior infection or vaccination.
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed "Omicron" spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charite - Univers
Rapid, low-cost, and accurate tests are still required for epidemiological surveillance and healthcare services to monitor and contain the spread of SARS-CoV-2. Brazilian researchers have contributed to this field's efforts by creating an electrochemical immunosensor that identifies antibodi
According to a study, individuals who have already been infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from a vaccination as well, with 60% to 94% protection against reinfection, depending on the variation.
According to a study, myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, particularly after the second mRNA-1273 (Moderna) vaccine, implying that vaccine type, age, and gender should all be taken into consideration when vaccinating.
Two recent papers by Brazilian researchers have added to the scientific understanding of the genetic factors that protect people from SARS-CoV-2 infection or prevent progression to severe COVID-19. The first describes the findings of a study involving a group of resilient older people aged 9
A novel nasal vaccination method has been created by researchers from the Centenary Institute and the University of Sydney that promotes strong lung immunity and protection against the SARS-CoV-2 coronavirus.